Subscribe For Free Updates!

We'll not spam mate! We promise.

Wednesday, June 18, 2014

CDC HIV/Hepatitis/STD/TB Prevention News Update 6/18/2014

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

HIV/Hepatitis/STD/TB News - CDC Prevention News Update

"PNU is a prevention and treatment news summary service. NPIN redistributes summaries as a public service. Inclusion of an article does not constitute CDC endorsement of the content. More details in footer."

NOTICE

Due to a reduction in funding and competing government priorities the daily CDC HIV/AIDS, Viral Hepatitis, STD and TB Prevention News Update (PNU) service is being discontinued as of June 30, 2014. Between now and June 30, the PNU frequency will change to three times per week. While the government understands the convenience of this service for our stakeholders we hope that you will be able to utilize one of the available news alerts from search engines such as Google and Yahoo to receive disease specific news.

CDCNPIN Prevention Newsletter 6/18/2014
National News

Joint Commission Alerts Healthcare Industry to Prevalence of Unsafe Injection Practices

International News

Patients to Be Screened for Extensively Drug-Resistant TB at CMCH from July 1

Medical News

Pressure to Conform to Perceived Masculine Norms May Fuel HIV Risk Among Gay Black Men

Local and Community News

City Offers Needle Exchange

News Briefs

Free HIV Tests Offered Next Week Through Planned Parenthood

FDA Approves AbbVie's Hepatitis C Regimen for Priority Review

National News
National News Joint Commission Alerts Healthcare Industry to Prevalence of Unsafe Injection Practices

UNITED STATES :: Viral Hepatitis
Infection Control Today (06.16.2014)

Infection Control Today reported that to curb the spread of hepatitis and other communicable diseases through the mishandling of injection vials, the US Joint Commission released a Sentinel Event Alert, “Preventing Infection from the Misuse of Vials.” The alert targets healthcare workers and organizations on the risk of misuse and reuse of single-dose vials and reusing syringes in multi-use vials. CDC stated there have been 49 reported outbreaks since 2001 from mishandling of injectable medical products; lapses in infection control often go unreported so an accurate number is unknown.

The alert provides strategies to improve factors that contribute to mishandling vials. Single-dose vials usually do not contain preservatives, which mean they harbor bacteria and infections. Using them more than once has the potential to carry the contamination to the next patient. Multi-dose vials are meant for more than one dose on the same patient, but a survey of healthcare practitioners showed that some workers reported using the same vial on different patients. This could expose patients to hepatitis B or C viruses and other infections. CDC reports outbreaks in both inpatient and outpatient healthcare facilities. Most outpatient locations were at cancer clinics or pain management clinics.

The Joint Commission derived information for the alert from its Sentinel Event Database, a comprehensive voluntary healthcare reporting system for serious harmful events that includes detailed information about the events and their underlying causes. Past issues of the Sentinel Event Alert can be found on the Joint Commission Web site at www.jointcommission.org.
Read Full Article

Share this Article Share on Facebook Share on Twitter Share on LinkedIn Share on Google+

Back to Top

International News
International News Patients to Be Screened for Extensively Drug-Resistant TB at CMCH from July 1

INDIA :: TB
The Hindu (06.16.2014) :: By R. Sairam

The Hindu reported that as of July 1, Coimbatore Medical College Hospital (CMCH) will begin immediately testing all multidrug-resistant (MDR) TB patients for extensively drug-resistant (XDR) TB when they request treatment. MDR TB is resistant to the first-line TB drugs isoniazid and rifampicin, while XDR TB is resistant to those drugs as well as second-line drugs. The hospital now is equipped to conduct the cartridge-based nucleic acid amplification test to diagnose MDR TB.

At present, CMCH screens MDR TB patients for XDR TB after six months of treatment. Intermediate Reference Laboratory in Kerala conducts the XDR TB tests and the results take three months to process. According to a senior official in the TB Directorate, XDR TB has a 25-percent mortality rate and a mortality rate as high as 50–70 percent in HIV/TB-coinfected patients, even for patients who start treatment in the early stages of the disease. With the earlier XDR TB testing, clinicians will receive earlier diagnoses, at three months rather than nine months. This means XDR TB treatment could begin earlier, thus improving patients’ chances of survival. The TB Directorate official encourages private doctors with TB patients to use the facility free of charge.
Read Full Article

Share this Article Share on Facebook Share on Twitter Share on LinkedIn Share on Google+

Back to Top

Medical News
Medical News Pressure to Conform to Perceived Masculine Norms May Fuel HIV Risk Among Gay Black Men

UNITED STATES :: HIV/AIDS
Medical Xpress (06.12.2014) :: By Ekaterina Pesheva

Medical Xpress reported on a study of family and cultural pressures to exhibit prescribed masculine behaviors among young black men who have sex with men (MSM). Errol Fields, MD, PhD, an adolescent medicine expert at the Johns Hopkins Children’s Center, and colleagues analyzed interview responses of 35 black openly gay and bisexual men and MSM who do not identify as gay or bisexual between the ages of 18 and 24.

The participants were raised in families and communities with homophobic attitudes and traditional views of masculinity. Participants reported that if they did not conform to expected behaviors, then they were ridiculed and ostracized. Under such pressures, participants were: more likely to engage in risky sexual behaviors; less likely to have monogamous relationships; and more likely to participate in unprotected sex. In addition, family rejection resulted in seeking affirmation and acceptance through sex, which often led to unsafe sex. According to some participants, unprotected sex was an expression of a sexual partner’s love and trust.

According to Fields, the findings show “a clear clash between internal sexual identity and external expectations at a critical developmental stage,” resulting in loneliness and low self-esteem, which led to risky behaviors. Researchers noted that in their desire to assimilate, youth engaged in risk-taking behaviors including fighting, aggression, drinking, and using drugs to prove their manhood. Also, the constant effort to present a straight appearance resulted in chronic anxiety and fear of discovery. Participants who were overtly masculine in public were more likely to avoid HIV prevention messages and services focusing on the gay community.

Researchers concluded that gay black youth may face more severe distress due to their homosexuality than youth from other racial groups and the resulting compensatory behavior may contribute to their high HIV infection rate. Fields emphasized the need for public health and primary care physicians to be aware of these cultural dynamics and provide appropriate sexual health counseling and interventions.

The full report, “‘I Always Felt I Had to Prove My Manhood’: Homosexuality, Masculinity, Gender Role Strain, and HIV Risk Among Young Black Men Who Have Sex with Men,” was published online ahead of print in the American Journal of Public Health (2014; doi: 10.2105/AJPH.2013.301866).
Read Full Article

Share this Article Share on Facebook Share on Twitter Share on LinkedIn Share on Google+

Back to Top

Local and Community News
Local and Community News City Offers Needle Exchange

WISCONSIN :: Viral Hepatitis
Journal Times (Racine) (06.17.2014) :: By Cara Spoto

The Journal Times reported that to curb a spike in HIV and hepatitis, Wisconsin’s City of Racine Health Department began a needle-exchange program this week in its City Hall clinic at 730 Washington Avenue. Last year, Racine reported 19 new HIV cases, compared to 11 from the previous year. The department estimates that 70 percent of city’s 60 new hepatitis C cases were related to heroin users who shared needles. The exchange program, the only one in the county, provides new sterile syringes to users in exchange for used needles to ensure proper disposal and eliminate the possibility of spreading disease.

“Most often when drug users are going to acquire HIV, hepatitis, or other diseases, it’s during the first 12 months of their use. And there (was) no service of this kind in Racine County,” said Dottie-Kay Bowersox, the city’s public health administrator. Bowersox said the department found motivation to provide a local needle-exchange program when it realized that many residents were being serviced by needle-exchange programs in nearby communities.

Users looking for clean needles inform clinic staff they are there for a needle exchange. The swap will take place in an examination room without the exchange of any personal contact information. However, staff will give clients a list of services and programs to help them quit drugs and fight their addiction.

Racine Police Chief Art Howell said the exchange program is meant to highlight the deadly cost of sharing used needles and should not be interpreted as “an official approval to consume illegal drugs.” Needle-exchange hours are Monday–Friday 8:00–11:55 a.m. and 1:00–4:55 p.m. in Room 4 on the lower level of City Hall. Individuals can obtain additional information by calling the City of Racine Health Department at (262) 636–9201, or by visiting the department’s Web site at www.cityofracine.org/Health.aspx.
Read Full Article

Share this Article Share on Facebook Share on Twitter Share on LinkedIn Share on Google+

Back to Top

News Briefs
News Briefs Free HIV Tests Offered Next Week Through Planned Parenthood

MICHIGAN :: HIV/AIDS
MLIve Michigan (06.16.2014) :: By Sue Thoms

MLive reported that in recognition of National HIV Testing Day on June 27, Planned Parenthood of West and Northern Michigan will offer free HIV tests at its eight health clinics from June 23 through 27. The clinics are located in Grand Rapids, Wyoming, Ionia, Muskegon, Big Rapids, Traverse City, Petoskey, and Marquette. Call (800) 230–7526 to make an appointment for testing. According to Bridget White, Planned Parenthood’s vice president of medical services, more than 1.1 million individuals in the United States are HIV-positive; approximately one in six do not know they are infected. She noted that the sooner individuals know their status, the sooner they can get information and treatment if needed, depending on test results.
Read Full Article

Share this Article Share on Facebook Share on Twitter Share on LinkedIn Share on Google+

Back to Top

  FDA Approves AbbVie's Hepatitis C Regimen for Priority Review

UNITED STATES :: Viral Hepatitis
Tech Times (06.15.2014) :: By Nicole Arce

TechTimes reported that the US Food and Drug Administration (FDA) has granted priority review for Illinois-based drug manufacturer AbbVie’s experimental all-oral regimen for treating adults infected with hepatitis C virus (HCV). The drug’s application under priority review means that FDA must evaluate the safety and effectiveness of the AbbVie regimen within six months before letting the manufacturer know whether they may take the product to market. FDA first granted breakthrough therapy designation to the manufacturer’s investigational treatment for chronic genotype 1 HCV in May 2013 when preliminary clinical evidence showed that the regimen led to better results than conventionally accepted treatments. AbbVie’s new regimen consists of an antiviral called ritonavir and a protease inhibitor called ABT-450, combined with an NS5A inhibitor called ombitasvir and the polymerase inhibitor dasabuvir. When taken together, these mechanisms are powerful enough to stop HCV.
Read Full Article

Share this Article Share on Facebook Share on Twitter Share on LinkedIn Share on Google+

Back to Top

The CDC National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention provides the above information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, viral hepatitis, other sexually transmitted diseases, and tuberculosis does not constitute CDC endorsement. The above summaries were prepared without conducting any additional research or investigation into the facts and statements made in the articles being summarized, and therefore readers are expressly cautioned against relying on the validity or invalidity of any statements made in these summaries. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/Hepatitis/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted above for full texts of the articles.

The Prevention News Update electronic mailing list is maintained by the National Prevention Information Network (NPIN), part of the Centers for Disease Control and Prevention's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Regular postings include the Prevention News Update, select articles from the Morbidity and Mortality Weekly Report series, and announcements about new NPIN products and services.

 

Socializer Widget By Trang Anh Nam
SOCIALIZE IT →
FOLLOW US →
SHARE IT →

0 comments:

Post a Comment